BRCAness: a deeper insight into basal-like breast tumors

Autor: De Summa, S., Pinto, R., Sambiasi, D., Petriella, D., Paradiso, V., Paradiso, A., Tommasi, S. ^*

Publikováno v: In Annals of Oncology November 2013 24 Supplement 8

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

Autor: De Lena, M. ^*, Lorusso, V., Latorre, A., Fanizza, G., Gargano, G., Caporusso, L., Guida, M., Catino, A., Crucitta, E., Sambiasi, D., Mazzei, A.

Publikováno v: In European Journal of Cancer February 2001 37(3):364-368

Six low-penetrance SNPs for the estimation of breast cancer heritability: A family-based study in Caucasian Italian patients.

Autor: De Summa S; Molecular Genetics Laboratory, IRCCS, Istituto Tumori 'Giovanni Paolo II', I-70124 Bari, Italy., Graziano F; Department of Brain and Behavioral Sciences, Section of Biostatistics, NeuroPhysiology and Psychiatry, Unit of Medical Statistics and Genomics, University of Pavia, I-27100 Pavia, Italy., Pilato B; Molecular Genetics Laboratory, IRCCS, Istituto Tumori 'Giovanni Paolo II', I-70124 Bari, Italy., Pinto R; Molecular Genetics Laboratory, IRCCS, Istituto Tumori 'Giovanni Paolo II', I-70124 Bari, Italy., Danza K; Molecular Genetics Laboratory, IRCCS, Istituto Tumori 'Giovanni Paolo II', I-70124 Bari, Italy., Lacalamita R; Molecular Genetics Laboratory, IRCCS, Istituto Tumori 'Giovanni Paolo II', I-70124 Bari, Italy., Serratì S; Molecular Genetics Laboratory, IRCCS, Istituto Tumori 'Giovanni Paolo II', I-70124 Bari, Italy., Sambiasi D; Familial Hereditary Cancer Study Unit, IRCCS, Istituto Tumori 'Giovanni Paolo II', I-70124 Bari, Italy., Grassi M; Department of Brain and Behavioral Sciences, Section of Biostatistics, NeuroPhysiology and Psychiatry, Unit of Medical Statistics and Genomics, University of Pavia, I-27100 Pavia, Italy., Tommasi S; Molecular Genetics Laboratory, IRCCS, Istituto Tumori 'Giovanni Paolo II', I-70124 Bari, Italy.

Publikováno v: Oncology letters [Oncol Lett] 2017 Oct; Vol. 14 (4), pp. 4384-4390. Date of Electronic Publication: 2017 Aug 04.

Comment on 'Renewed interest in the progesterone receptor in breast cancer'.

Autor: Simone G; Pathology Unit, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy., Diotaiuti S; Senology Unit, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy., Digennaro M; Experimental Medical Oncology, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy., Sambiasi D; Experimental Medical Oncology, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy., De Summa S; Molecular Genetics, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy., Tommasi S; Molecular Genetics, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy., Altieri R; Senology Unit, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy., Mangia A; Functional Biomorphology, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy., Dantona C; Department of General Surgery,Ospedale Civico di Lugano, Via Tesserete 46, 6900 Lugano, Switzerland., Paradiso A; Experimental Medical Oncology, Istituto Tumori Giovanni Paolo II, IRCCS, National Cancer Research Institute, via O Flacco 65, Bari I-70124, Italy.

Publikováno v: British journal of cancer [Br J Cancer] 2017 Jul 11; Vol. 117 (2), pp. e1. Date of Electronic Publication: 2017 Apr 11.

GSH-responsive degradable nanodrug for glucose metabolism intervention and induction of ferroptosis to enhance magnetothermal anti-tumor therapy.

Autor: Liao, Zhen¹ (AUTHOR), Wen, E.² (AUTHOR), Feng, Yi³ (AUTHOR) fengxiaoyijoy@163.com

Publikováno v: Journal of Nanobiotechnology. 4/3/2024, Vol. 22 Issue 1, p1-17. 17p.